We are thrilled to share our participation in the 44th Annual Meeting of the Japan Society of Clinical Pharmacology. As an organisation deeply committed to advancing clinical pharmacology and fostering the convergence of life, science, and medicine, we eagerly anticipate the insights and collaboration that this event will undoubtedly bring.

Symposium Spotlight - Room 6 - December 15 (Fri) 16:20~17:50

We are honoured to be part of Symposium 31, where our distinguished experts will delve into compelling topics shaping the landscape of clinical trials in the United Kingdom. Join us for an insightful exploration:

First in Human Clinical Trials in the United Kingdom – Past, Present and Future?

Presented by Jorg Taubel, CEO of Richmond, this session promises to offer a comprehensive overview of the historical milestones, current practices, and the exciting future of first-in-human clinical trials in the UK.

Certification of early phase principal investigators’ capabilities: innovative trial designs, advanced therapies, and collaborative working

Led by Ulrike Lorch, Chief Medical Director at Richmond, this presentation will spotlight the innovative trial designs, advanced therapies, and collaborative approaches that define the certification of early-phase principal investigators' capabilities.

We are confident that these sessions will provide valuable insights, fostering dialogue on the forefront of clinical pharmacology and early-phase clinical trials. Our CEO and Chief Medical Director's expertise will undoubtedly contribute to the enriching discussions during this symposium.

Richmond Pharmacology is honoured to be part of this event, and we look forward to engaging with fellow professionals, sharing knowledge, and forging connections.

To find out more https://convention.jtbcom.co.jp/kusuri-kobe2023/44jcpt/summary/index.html 

Latest news

Richmond Pharmacology Announces Promotion of Dr Priscilla Ochuba to Associate Medical Director

August 1, 2025
Richmond Pharmacology is pleased to announce the promotion of Dr Priscilla Ochuba to Associate Medical Director, effective 1st August 2025.
Read more

Red4Research Blog – Alan’s Story

June 24, 2025
#Red4Research is a global initiative that recognises the essential role of clinical research in improving treatment, outcomes, and the future of medicine.
Read more

Events

JSCPT 2025

5th –6th December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event